Genetic risk factors in Parkinson's disease

Annals of Neurology

Volumn 44, Issue 3 SUPPL. 1, 1998, Pages

  Wood, Nicholas W ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 0031696267     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410440709     Document Type: Conference Paper

References (53)

1. Johnson WG, Hodge SE, Duvoisin R. Twin studies and the genetics of Parkinson's disease - a reappraisal. Mov Disord 1990;5:187-194
2. Polymeropoulos MH. Autosomal dominant Parkinson's disease and α-synuclein. Ann Neurol 1998;44(Suppl 1):S63-S64 (this issue)
3. Gasser T. Genetics of Parkinson's disease. Ann Neurol 1998; 44(Suppl 1):S53-S57 (this issue)
4. Marsden CD. Parkinson's disease in twins [letter]. J Neurol Neurosurg Psychiatry 1987;50:105-106
5. Ward CD, Duvoisin RC, Ince SE, Nutt JD, Eldridge R, Calne DB. Parkinson's disease in 65 pairs of twins and in a set ot quadruplets. Neurology 1983;33:815-824
6. Vieregge P, Schiffke KA, Friedrich HJ, Muller B, Ludin HP. Parkinson's disease in twins. Neurology 1992;42:1453-1461
7. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997;276:2045-2047
8. Polymeropoulos MH, Higgins JJ, Golbe LI, et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science 1996;274:1197-1199
9. Langston W. Epidemiology versus genetics in Parkinson's disease: progress in resolving an age-old debate. Ann Neurol 1998;44(Suppl 1):S45-S52 (this issue)
10. De Michele G, Filla A, Volpe G, et al. Environmental and genetic risk factors in Parkinson's disease: a case-control study in southern Italy. Mov Disord 1996;11:17-23
11. Marder K, Tang MX, Mejia H, et al. Risk of Parkinson's disease among first-degree relatives: a community-based study. Neurology 1996;47:155-160
12. Seidler A, Hellenbrand W, Robra BP, et al. Possible environmental, occupational, and other etiologic factors tor Parkinson's disease: a case-control study in Germany. Neurology 1996;46: 1275-1284
13. Payami H, Larsen K, Bernard S, Nutt J. Increased risk of Parkinson's disease in parents and siblings of patients. Ann Neurol 1994;36:659-661
14. Gasser T, Muller Myhsok B, Wszolek ZK, et al. Genetic heterogeneity in familial parkinsonism: no linkage to the PD-1 locus on chromosome 4q in 11 of 13 families. Science 1997;277: 388-389
15. Waters CH, Miller CA. Autosomal dominant Lewy body parkinsonism in a four-generation family. Ann Neurol 1994;35: 59-64
16. Wszolek ZK, Pfeiffer B, Fulgham JR, et al. Western Nebraska family (family D) with autosomal dominant parkinsonism. Neurology 1995;45:502-505
17. Markopoulou K, Wszolek ZK, Pfeiffer RF. A Greek-American kindred with autosomal dominant, levodopa-responsive parkinsonism and anticipation [see comments]. Ann Neurol 1995;38: 373-378
18. Hughes A, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study. J Neurol Neurosurg Psychiatry 1992;55: 181-184
19. Bandmann O, Marsden CD, Wood NW. Genetic aspects of Parkinson's disease. Mov Disord 1998;13:203-211
20. Armstrong M, Daly AK, Cholerton S, Bateman DN, Idle JR. Mutant debrisoquine hydroxylation genes in Parkinson's disease. Lancet 1992;339:1017-1018
21. Bandmann O, Vaughan J, Holmans P, Marsden CD, Wood NW. Association of slow acerylator genotype for N-acetyltransferase 2 with familial Parkinson's disease. Lancet 1997;350:1136-1139
22. Bordet R, Broly F, Destee A, Libersa C. Genetic polymorphism of cytochrome P450 2D6 in idiopathic Parkinson disease and diffuse Lewy body disease. Clin Neuropharmacol 1994;17:484-488
23. Diederich N, Hilger C, Goetz CG, et al. Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol 1996;40:463-465
24. Gasser T, Muller Myhsok B, Supala A, et al. The CYP2D6B allele is not over represented in a population of German patients with idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;61:518-520
25. Kosel S, Lucking CB, Egensperger R, Mehraein P, Graeber MB. Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body parkinsonism. J Neurosci Res 1996;44: 174-183
26. Kurth MC, Kurth JH. Variant cytochrome P450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 1993; 48:166-168
27. Landi MT, Ceroni M, Martignoni E, Bertazzi PA, Caporaso NE, Nappi G. Gene-environment interaction in Parkinson's disease. The case of CYP2D6 gene polymorphism. Adv Neurol 1996;69:61-72
28. Plante Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE. Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:911-913
29. Ray Chaudhuri K, Smith C, Gough AC, et al. Debrisoquine hydroxylase gene polymorphism in Parkinson's disease and amyotrophic lateral sclerosis [letter]. J Neurol Neurosurg Psychiatry 1995;58:109
30. Saitoh T, Xia Y, Chen X, et al. The CYP2D6B mutant allele is overrepresented in the Lewy body variant of Alzheimer's disease. Ann Neurol 1995;37:110-112
31. Sandy MS, Armstrong M, Tanner CM, et al. CYP2D6 allelic frequencies in young-onset Parkinson's disease. Neurology 1996;47:225-230
32. Smith CA, Gough AC, Leigh PN, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease [published erratum, Lancet 1992;340:64]. Lancet 1992; 339:1375-1377
33. Tsuneoka Y, Matsuo Y, Iwahashi K, Takeuchi H, Ichikawa Y. A novel cytochrome P-450IID6 mutant gene associated with Parkinson's disease. J Biochem (Tokyo) 1993;114:263-266
34. Semchuk K, Love E, Lee R. Parkinson's disease: a test of the multifactorial etiologic hypothesis. Neurology 1993;43:1173-1180
35. Gasser T, Wszolek ZK, Trofatter J, et al. Genetic linkage studies in autosomal dominant parkinsonism: evaluation of seven candidate genes. Ann Neurol 1994;36:387-396
36. Plante Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE. Tyrosine hydroxylase polymorphism in familial and sporadic Parkinson's disease. Mov Disord 1994;9: 337-339
37. Parboosingh JS, Rousseau M, Rogan F, et al. Absence of mutations in superoxide dismutase and catalase genes in patients with Parkinson's disease. Arch Neurol 1995;52:1160-1163
38. Bandmann O, Davis MB, Marsden CD, Harding AE. Sequence of the superoxide dismutase 1 (SOD 1) gene in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1995;59:90-91
39. Arai H, Higuchi S, Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer's disease. Gerontology 1997;43(Suppl 1): 2-10
40. Arai H, Muramatsu T, Higuchi S, Sasaki H, Trojanowski JQ. Apolipoprotein E gene in Parkinson's disease with or without dementia. Lancet 1994;344:889
41. Ibarreta D, Gomez Isla T, Portera Sanchez A, Parrilla R, Ayuso MS. Apolipoprotein E genotype in Spanish patients of Alzheimer's or Parkinson's disease. J Neurol Sci 1995;134:146-149
42. Koller WC, Glatt SL, Hubble JP, et al. Apolipoprotein E genotypes in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-245
43. Rubinsztein DC, Hanlon CS, Irving RM, et al. Apo E genotypes in multiple sclerosis, Parkinson's disease, Schwannomas and late-onset Alzheimer's disease. Mol Cell Probes 1994;8: 519-525
44. Whitehead AS, Bertrandy S, Finnan F, Butler A, Smith GD, Ben-Shlomo Y. Frequency of the apolipoprotein E epsilon 4 allele in a case-control study of early onset Parkinson's disease. J Neurol Neurosurg Psychiatry 1996;61:347-351
45. Hotamisligil GS, Girmen AS, Fink JS, et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord 1994;9:305-310
46. Ho SL, Kapadi AL, Ramsden DB, Williams AC. An allelic association study of monoamine oxidase B in Parkinson's disease. Ann Neurol 1995;37:403-405
47. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD. Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372
48. Plante Bordeneuve V, Taussig D, et al. Evaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease: evidence for association of a DRD2 allele. Neurology 1997;48:1589-1593
49. Yamamoto M, Kondo I, Ogawa N, Asanuma M, Yamashita Y, Mizuno Y. Genetic association between susceptibility to Parkinson's disease and alpha 1-antichymotrypsin polymorphism. Brain Res 1997;759:153-155
50. Kurth JH, Kurth MC. Allele frequencies of tyrosine hydroxylase in Parkinson's disease patients. Mov Disord 1992;7:290
51. Bandmann O, Sweeney MG, Daniel SE, Marsden CD, Wood NW. Mitochondrial DNA polymorphisms in pathologically proven Parkinson's disease. J Neurol 1997;244:262-265
52. Daly AK, Cholerton S, Armstrong M, Idle JR. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994;102(Suppl 9): 55-61
53. Takakubo F, Yamamoto M, Ogawa N, Yamashita Y, Mizuno Y, Kondo I. Genetic association between cytochrome P450IA1 gene and susceptibility to Parkinson's disease. J Neural Transm [Gen Sect] 1996;103:843-849